Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PREMILOC: Hydrocortisone for BPD Prevention in Very Preterm Infants
NCT00623740Phase 3Completed
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Apr 2008
- Primary completion
- Jan 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of hydrocortisone in bronchopulmonary dysplasia (BPD), sponsored by Assistance publique - Hôpitaux de Paris. Started Apr 2008; status: completed.
02
Drugs
hydrocortisone
03
Conditions
bronchopulmonary dysplasia (BPD)
Beyond the preview
Go deeper on NCT00623740.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00623740.